article thumbnail

Big Pharma leading in access-to-medicine strategies, shows data

European Pharmaceutical Review

To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. Novartis signed the first licence for a non-communicable disease (NCD) product, a leukaemia medicine.

article thumbnail

Is digital the future of medicine?

World of DTC Marketing

Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June. ” Digital medicine also needs better clarification.

Medicine 201
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NICE recommends first medicine for severe alopecia areata

European Pharmaceutical Review

This is “an important milestone” according to Lynn Clay, Specialty Care Lead at Pfizer UK. However, on 31 October 2023, a marketing authorisation in Great Britain was granted for the medicine ritlecitinib. “It The post NICE recommends first medicine for severe alopecia areata appeared first on European Pharmaceutical Review.

article thumbnail

Ethnopharmacology: traditional medicine and modern drug discovery

Pharmaceutical Technology

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.

Medicine 105
article thumbnail

EMA issues guidance amidst European medicine shortage

Pharmaceutical Technology

The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.

article thumbnail

EMA guidance aims to prevent medicine shortages

European Pharmaceutical Review

A new document published by European Medicines Agency (EMA) makes ten recommendations and outlines good practices “to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact.” Medicine shortages are a global health problem and are increasingly affecting European countries, according to EMA.

article thumbnail

Leading innovators in recombinant viral vector-based medicinal preparations for the pharmaceutical industry

Pharmaceutical Technology

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Recombinant viral vector-based medicinal preparations. However, not all innovations are equal and nor do they follow a constant upward trend.